Stock 3759 PHARMARON BEIJING CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Pharmaron Beijing Co., Ltd. Hong Kong S.E.

Equities

3759

CNE100003PG4

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:05 2024-05-31 EDT 		5-day change 1st Jan Change
9.83 HKD +2.50% Intraday chart for Pharmaron Beijing Co., Ltd. -4.00% -37.86%
05-20 Pharmaron Beijing Unit to Sell Proteologix Stake to Johnson & Johnson MT
05-16 Johnson & Johnson entered into a definitive agreement to acquire Proteologix, Inc. from Pharmaron Beijing Co., Ltd and other shareholders for approximately $100 million. CI

Evolution of the average Target Price on Pharmaron Beijing Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

faf14.5FITeelKutNETnIgbt8uEmHnGeY0dxfPIMvG0pfoCto.qRtqNbp-w-MhOTN1K-kDVBGmd6B3Tk6WWa2Pht-fToXcOUIcjCLquzUDKw~c82670ee91d63f8feb50c1f864ea9340

Analyst Recommendations on Pharmaron Beijing Co., Ltd.

Nomura Adjusts Pharmaron’s Price Target to 31.41 Yuan From 36.68 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing Co's Price Target to HK$15.41 From HK$17.99, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing’s Price Target to HK$17.99 From HK$30.92, Keeps at Buy MT
Nomura Adjusts Pharmaron’s Price Target to 61.24 Yuan From 66.94 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron’s Price Target to 66.94 Yuan From 73.38 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron’s Price Target to HK$36.24 From HK$40.03, Keeps at Buy MT
Nomura Adjusts Pharmaron’s Price Target to 73.38 Yuan From 85.63 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron's Price Target to HK$60.04 From HK$69.02, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to 85.63 Yuan From 90.01 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to HK$69.02 From HK$62.19, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to 90.01 Yuan From 99.95 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to HK$62.19 From HK$91.89, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to 99.95 Yuan From 103.74 Yuan, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to HK$91.89 From HK$94.89, Keeps at Buy MT
UBS Adjusts Pharmaron’s Price Target to HK$149 From HK$240, Keeps at Buy MT
Nomura Adjusts Pharmaron Beijing's Price Target to HK$141.62 From HK$178.52, Keeps at Buy MT
Nomura Adjusts Pharmaron's Price Target to 154.84 Yuan From 203.32 Yuan, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
20.64 CNY
Average target price
24.15 CNY
Spread / Average Target
+16.99%
High Price Target
40 CNY
Spread / Highest target
+93.80%
Low Price Target
9.1 CNY
Spread / Lowest Target
-55.91%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Pharmaron Beijing Co., Ltd.

Nomura
UBS

Ratings for Pharmaron Beijing Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 300759 Stock
  4. 3759 Stock
  5. Consensus Pharmaron Beijing Co., Ltd.